Nephrology focuses on diagnosing and treating kidney diseases. The kidneys filter waste, balance fluids, regulate blood pressure, and manage acute and chronic conditions.
Send us all your questions or requests, and our expert team will assist you.
We can’t “fix” the broken genes that cause renal genetic diseases, but there are treatments. On the contrary, the management of these conditions is active and effective. The goal of treatment is to protect the kidneys, slow down the progression of damage, and manage the symptoms to ensure a high quality of life. Modern medicine offers many tools, from medications that target specific biological pathways to lifestyle changes that reduce the workload on the kidneys. Follow-up is a lifelong partnership with your medical team, ensuring that as your body changes, your care plan adapts with it.
Much of the treatment focuses on handling the day-to-day effects of the disease. Pain management is a priority for conditions like Polycystic Kidney Disease (PKD), where cysts can cause discomfort. Doctors often recommend non-medication approaches first, like heating pads or ice, followed by safe pain relievers like acetaminophen. Non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen are generally avoided because they can hurt the kidneys.
If kidney stones are a problem, treatment involves dietary changes to prevent them and medications to help pass them. For hearing loss associated with Alport syndrome, regular visits to an audiologist and the use of hearing aids are standard care. Treating these “side effects” of the genetic condition helps patients maintain a normal, active life despite their diagnosis.
Controlling blood pressure is the single most important thing a patient can do to slow down kidney disease. High blood pressure pounds the delicate filters of the kidney, causing them to scar faster. In genetic diseases, the kidneys often lose their ability to regulate pressure properly, creating a vicious cycle.
Doctors typically prescribe a class of drugs known as ACE inhibitors or ARBs. These medicines are special because they do two things: they lower blood pressure in the whole body, and they specifically reduce the pressure inside the kidney filters. This dual action protects the kidney tissue. The goal is usually to keep blood pressure lower than average, often below 130/80, to provide maximum protection.
For some genetic conditions, specific drugs have been developed that target the mechanism of the disease. The most famous example is tolvaptan for autosomal dominant polycystic kidney disease (ADPKD).
Tolvaptan works by blocking a hormone called vasopressin. Vasopressin normally tells the kidney to hold onto water, but in PKD patients, it also tells the cysts to grow. By blocking this hormone, tolvaptan slows down the growth of cysts and preserves kidney function for longer. It is not a cure, but it can buy patients extra years before they might need dialysis. Using this drug requires careful monitoring because it causes extreme thirst and frequent urination, as the body releases large amounts of water.
Follow-up appointments are the safety net of renal care. Patients with genetic kidney disease typically see their nephrologist every 6 to 12 months, or more often if their function is declining. During these visits, the doctor checks the “numbers”—specifically the creatinine and glomerular filtration rate (GFR).
They are looking for the rate of decline. Is the kidney function stable, or is it dropping quickly? This trajectory helps them plan for the future. They also monitor urine protein levels. If protein is increasing, they might increase the dose of blood pressure medication. They also check for complications like anemia (low red blood cells) or bone mineral imbalances, which are common as kidney function worsens.
For many patients with severe genetic kidney disease, there may come a time when the kidneys can no longer keep up with the body’s needs. This is called End-Stage Renal Disease (ESRD). At this point, renal replacement therapy is needed.
Dialysis is a machine-based treatment that filters the blood. It can be done at a clinic or at home. While it keeps a patient alive, it is demanding.
Transplantation is often the best treatment for genetic kidney disease. This procedure involves surgically placing a healthy kidney from a donor into the patient’s body. For genetic patients, there is a special consideration: the donor must be screened carefully. You would not want to receive a kidney from a sibling who has the same genetic disease but hasn’t been diagnosed yet. Therefore, genetic testing of family donors is mandatory. The good news is that for most genetic diseases, the new kidney will not get it (since the new kidney has “healthy” DNA).
Treating a genetic disease often means treating the whole family.
For a parent with a dominant condition, the procedure means testing their children. The timing of this testing is a personal choice and often involves ethical discussions. Some parents wait until the child is an adult so the child can decide; others test early to start monitoring blood pressure immediately. Follow-up for affected family members ensures they are not overlooked. It allows them to start protective measures like low-salt diets and blood pressure monitoring years before they might otherwise have realized they were sick.
The field of renal genetics is moving fast. Clinical trials are currently testing new drugs that might stop cysts from forming or repair the collagen in Alport syndrome. There is even research into gene therapy—the idea of delivering a correct copy of the gene into the kidney cells to fix the error.
While gene therapy is still in the experimental stages for kidneys, other treatments like SGLT2 inhibitors (originally for diabetes) are showing promise in slowing down various forms of chronic kidney disease. Staying in touch with a specialist ensures that patients have access to these new therapies as soon as they become available.
Send us all your questions or requests, and our expert team will assist you.
Not necessarily. Many people with genetic kidney disease have mild forms and live their whole lives without their kidneys failing. It depends on your specific mutation and how well you manage your health.
Tolvaptan is specifically for ADPKD (Polycystic Kidney Disease) patients who are at risk of rapid progression. It is not for every genetic condition. Your doctor can determine if you qualify.
Yes, but only if they do not have the genetic disease. They must undergo rigorous genetic testing to ensure they are truly unaffected before they can donate.
For PKD specifically, drinking plenty of water is often recommended because it naturally lowers the vasopressin hormone, which drives cyst growth. Ask your doctor for a specific fluid goal.
Yes, moderate exercise is excellent for blood pressure. However, if you have large cysts, you may need to avoid contact sports (like football) to prevent them from rupturing.
Your Comparison List (you must select at least 2 packages)
